Woojeong Bio, Gene Therapy/Analysis Theme Rises 5.05%

On the 14th, the gene therapy/analysis theme showed strength by rising 4.53% compared to the previous day, while Woojung Bio, a related stock drawing attention, surged 5.05% compared to the previous day. Woojung Bio is known as a first-generation bio platform company in Korea.

[Graph] Major stock price changes in the gene therapy/analysis theme



According to the analysis by Thinkpool Robo Algorithm RASSI, Woojung Bio’s quant financial score is 18.56 points, ranking 7th within the gene therapy/analysis theme due to higher growth and profitability scores compared to the average of other stocks in the theme. This indicates that, compared to other stocks in the theme, Woojung Bio’s sales and net income growth rates are relatively fast, and its efficient profit-generating ability is also favorable.

[Table] Top stocks by financial score within the theme


※ The quant financial score is the result of the Robo Algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.

※ This article was generated in real time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.